Objective: To compare the efficacy and tolerability of a salmeterol/fluticasone propionate (FP ... consisting of a 2-week run-in and a 12-week treatment period. Results: The salmeterol/FP ...
Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide ... twice daily from a Diskus™ inhaler for a 4-week run-in period ...
Fluticasone propionate, salmeterol (as xinafoate); 45mcg/21mcg, 115mcg/21mcg, 230mcg/21mcg; per inh; metered-dose inhaler ... prophylaxis or antiviral treatment. Monitor for adrenal ...
News Medical on MSN7d
Study finds no clinical advantage of budesonide inhaler over fluticasone in COPDA study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...
Flovent Diskus is indicated for the maintenance treatment of asthma as ... mL after a 500-mcg twice-daily dose of fluticasone propionate inhalation powder using the Diskus inhaler.
and fluticasone-umeclidinium-vilanterol, a once-daily dry powder inhaler for treatment of COPD in routine clinical practice in a new-user, 1:1 propensity score-matched cohort study. The study ...
The abbreviated new drug application (ANDA) for the fluticasone propionate and salmeterol inhalation powder – named VR ... VR 315 is indicated for the treatment of both asthma and chronic ...
In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was ...
Seretide (salmeterol xinafoate/fluticasone propionate ... metered dose inhaler (pMDI) device developed by 3M. Like its branded rival, the new product is approved to help treat or prevent ...
For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback